GTG 5.06% 7.5¢ genetic technologies limited

GTGs biggest problem

  1. 1,287 Posts.
    lightbulb Created with Sketch. 209
    SALES!!!!!!!!!!

    GTG is unable to sell its genetic tests !!!!

    ASX Half-year ended 31 Dec 2018  -  Sales for 2017 = US$97,790
       Sales for 2018 = US$18,402

    In the Investor Presentation 02 May 2019 there is NO mention of sales !!!!  This presentation just mentions very vague words like "distribution channel"

    The big carrot of hope being dangled in front of investors is the "US$925 billion" healthcare market in China - the BREVAGenplus test is validated for Caucasian, African American and Hispanic women, but no indication it has been (or is currently being) validated for Asian women.
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
-0.004(5.06%)
Mkt cap ! $9.916M
Open High Low Value Volume
7.6¢ 8.1¢ 7.3¢ $18.25K 233.9K

Buyers (Bids)

No. Vol. Price($)
1 232 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 8905 1
View Market Depth
Last trade - 15.37pm 28/06/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.